Liz Parrish: Paving the way in cutting edge gene therapy innovations to treat diseases of aging

2 August 2018

Recently, an article was published on the website Outside publicising Liz Parrish, founder of BioViva, a company focused on health and longevity. BioViva believes that it is on the...

Read more

A Novel Gene Therapy To Treat One Of The World’s Biggest Growing Chronic Disease: Dementia and Alzhiemer’s

17 July 2018

Research studies indicate that telomerase gene therapy may not only reverse Alzheimer’s Disease and other dementias, but it may even protect people from developing...

Read more

Bioviva: Helping reduce the burden of chronic ageing

11 July 2018

What BioViva does as a company is vitally important. Throughout our lifetime, it is possible to achieve amazing things, but time is always a...

Read more

What prompted Elizabeth Parrish to set up BioViva?

4 July 2018

2013 was a difficult year for Elizabeth Parrish. Upon finding out that her son had type 1 diabetes. A condition with dangerous continuations of...

Read more

Bioviva, Gene Therapy And Blockchain Merges In Russia

15 June 2018

During June 20th to the 23rd, founder and CEO of BioViva USA Inc, Elizabeth Parrish visited Moscow at the invitation of board member of...

Read more

Gene Therapy For Sickle Cell Disease Passes Key Preclinical Test

13 May 2018

A precision-engineered gene therapy virus, inserted into blood stem cells that are then transplanted, markedly reduced sickle-induced red-cell damage in mice with sickle cell...

Read more

One Year Anniversary Of Bioviva’s Gene Therapy Against Human Aging

19 April 2018

It has officially been two and a half years since I volunteered to take the first gene therapy to treat biological aging. It has...

Read more

Dual Gene Therapy Has Beneficial Effects On Blood Biomarkers And Muscle Composition

21 March 2018

In April 2016 BioViva USA Inc. published a press release stating that Elizabeth Parrish, CEO, had experienced telomere lengthening in her leukocytes, as a...

Read more

BioViva Supports Patient Advocacy For Gene Therapy

17 March 2018

“Patient advocates are the driving force behind the development of many new drugs and amendments to medical regulations. It is the common man and...

Read more